Todos Medical Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
TOMDF Over the counter 8731 https://todosmedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Todos Medical Ltd

Todos Medical's Letter of Intent with Provista Diagnostics set to license sepsis diagnostic testing - Mar 31st, 2023 4:32 pm
Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics - Mar 28th, 2023 1:09 pm
Todos Medical Begins Trading on the OTC Pink Marketplace - Mar 27th, 2023 11:16 am
Todos Medical Supports Long COVID Awareness Day - Mar 15th, 2023 6:27 pm
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders - Mar 13th, 2023 11:26 pm
Todos Medical releases corporate update around validation plan for PCR-based Avian Influenza testing - Feb 27th, 2023 6:15 pm
Todos Medical Provides Corporate Update - Feb 23rd, 2023 3:30 pm
Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics - Feb 14th, 2023 2:06 pm
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference - Dec 6th, 2022 3:10 pm
Todos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022 - Nov 29th, 2022 1:23 pm
Todos Medical to Attend World Antiviral Congress - Nov 22nd, 2022 1:32 pm
Todos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail Network - Nov 16th, 2022 12:30 pm
Todos Medical Announces Third Quarter 2022 Financial Results - Nov 15th, 2022 1:30 pm
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022 - Nov 14th, 2022 11:26 pm
Todos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A. - Nov 10th, 2022 3:33 pm
Todos Medical Announces BioFuture™ NYC 2022 Presentation - Nov 4th, 2022 11:50 am
Todos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDA - Oct 14th, 2022 1:09 pm
Presenting on the Emerging Growth Conference on October 12 Register Now - Oct 11th, 2022 11:00 am
Todos Medical Announces Successful Pilot Launch of Suite of PCR Testing Services by CLIA/CAP Lab Provista Diagnostics - Oct 6th, 2022 12:00 pm
Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform - Sep 30th, 2022 1:59 pm